Clinical Trial Update: Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance [NA]

View source ↗

Summary

A completed clinical trial evaluated whether a common L-FABP polymorphism is associated with lipid-induced hepatic insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Snippet

Sponsor: German Institute of Human Nutrition | Conditions: Wildtype, Polymorphism Liver FABP | NA | Status: COMPLETED